Krebs Biochemicals & Industries Ltd
company logo

Krebs Biochemicals & Industries Ltd

Krebs Biochem Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Invest in Krebs Biochemicals & Industries Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Krebs Biochemicals & Industries Ltd Performance

-

-

-

-


-

-

-

-

-

Krebs Biochemicals & Industries Ltd Fundamentals

Read More

181.22Cr

0

0

2.83

0

0%

-60.36

Krebs Biochemicals & Industries Ltd Financials

Krebs Biochemicals & Industries Ltd Financialsright-arrow

Krebs Biochemicals & Industries Ltd Shareholding Pattern

Krebs Biochemicals & Industries Ltd Delivery and Volume

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech proc

Jitendra Shah

1991

KREBSBIO

NameDesignation
G V L PrasadIndependent Director
R T RaviChairman (Non-Executive)
Avinash RaviNon Executive Director
Tangirala MalatiIndependent Director
Satish KhivsaraIndependent Director
Raj Kamal Prasad VermaIndependent Director
Rohit TapariaCompany Sec. & Compli. Officer
Jitendra ShahManaging Director
Keyur DoshiCompany Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

View All
View All

Krebs Biochemicals & Industries Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Krebs Biochemicals & Industries Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Krebs Biochemicals & Industries Ltd's share price is ₹85.12 as of 2024-11-14.
Krebs Biochemicals & Industries Ltd's P/E ratio is - times as of 2024-11-14.
Krebs Biochemicals & Industries Ltd's most recent financial reports indicate a price-to-book ratio of -, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Krebs Biochemicals & Industries Ltd's market capitalization is ₹181.22 Cr as on 2024-11-14.
The current financial records of Krebs Biochemicals & Industries Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Krebs Biochemicals & Industries Ltd's most recent financial filings, the company has a total asset value of ₹17.44, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Krebs Biochemicals & Industries Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Krebs Biochemicals & Industries Ltd's 52-week high and low as of 2024-11-14 are ₹89.67 and ₹83.11, respectively.